{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:47:05Z","timestamp":1789001225560,"version":"build-2803163510"},"reference-count":143,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.dld.2024.05.002","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T20:56:10Z","timestamp":1718830570000},"page":"1461-1474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Position paper of the Italian Association for the Study of the Liver (AISF): Management and treatment of primary biliary cholangitis"],"prefix":"10.1016","volume":"56","author":[{"given":"M.","family":"Carbone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5086-0514","authenticated-orcid":false,"given":"A.","family":"Gerussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Cardinale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Cazzagon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0000-1076","authenticated-orcid":false,"given":"V.","family":"Cossiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0561-7902","authenticated-orcid":false,"given":"A.","family":"Lleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9475-3948","authenticated-orcid":false,"given":"G.","family":"Marrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Marzioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Moschetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Muratori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Rigamonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Vespasiani-Gentilucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7445-1328","authenticated-orcid":false,"given":"M.","family":"Fraquelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0287-1059","authenticated-orcid":false,"given":"V.","family":"Calvaruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2024.05.002_bib0001","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2024.05.002_bib0002","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/hep.29717","article-title":"Milder disease stage in patients with primary biliary cholangitis over a 44-year period: a changing natural history","volume":"67","author":"Murillo Perez","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2024.05.002_bib0003","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.jhep.2022.06.017","article-title":"Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis","volume":"77","author":"Corpechot","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2024.05.002_bib0004","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","article-title":"Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid","volume":"144","author":"Carbone","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.002_bib0005","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2014.08.029","article-title":"Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study","volume":"147","author":"Lammers","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.002_bib0006","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jaut.2018.10.015","article-title":"The immunobiology of female predominance in primary biliary cholangitis","volume":"95","author":"Gerussi","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.dld.2024.05.002_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094873","article-title":"The role of epigenetics in primary biliary cholangitis","volume":"23","author":"Gerussi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dld.2024.05.002_bib0008","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1053\/j.gastro.2021.02.061","article-title":"X chromosome contribution to the genetic architecture of primary biliary cholangitis","author":"Asselta","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.002_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2021.104292","article-title":"The genetic architecture of primary biliary cholangitis","volume":"64","author":"Gerussi","year":"2021","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.dld.2024.05.002_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep25906","article-title":"Evolving trends in female to male incidence and male mortality of primary biliary cholangitis","volume":"6","author":"Lleo","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2024.05.002_bib0011","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000179","article-title":"Primary biliary cholangitis: epidemiology, prognosis, and treatment","volume":"7","author":"Trivella","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.dld.2024.05.002_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2020.100202","article-title":"Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis","volume":"3","author":"Dyson","year":"2021","journal-title":"JHEP Reports"},{"key":"10.1016\/j.dld.2024.05.002_bib0013","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2024.05.002_bib0014","article-title":"Epidemiology of primary biliary cholangitis in Italy: evidence from a real-world database","author":"Marzioni","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2024.05.002_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2021.100248","article-title":"Real-world experience with obeticholic acid in patients with primary biliary cholangitis","author":"D'Amato","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.dld.2024.05.002_bib0016","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.dld.2024.05.002_bib0017","first-page":"535","article-title":"Antibodies to gp210 and understanding risk in patients with primary biliary cholangitis","volume":"41","author":"Haldar","year":"2021","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.dld.2024.05.002_bib0018","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.28017","article-title":"The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis","volume":"63","author":"Carbone","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2024.05.002_bib0019","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.cgh.2020.08.006","article-title":"Measurement of gamma glutamyl transferase to determine risk of liver transplantation or death in patients with primary biliary cholangitis","volume":"19","author":"Gerussi","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.05.002_bib0020","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hep.510270303","article-title":"Characterization of antimitochondrial antibodies in health adults","volume":"27","author":"Mattalia","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2024.05.002_bib0021","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/gast.2002.36027","article-title":"Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years","volume":"123","author":"Prince","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.002_bib0022","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/hep.21828","article-title":"Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis","volume":"46","author":"Leung","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2024.05.002_bib0023","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jcb.21595","article-title":"Characterization of the antibodies to p62 nucleoporin in primary biliary cirrhosis using human recombinant antigen","volume":"104","author":"W\u0229sierska-Ga\u0327dek","year":"2008","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.dld.2024.05.002_bib0024","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1440-1827.2009.02500.x","article-title":"Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: interobserver agreement","volume":"60","author":"Nakanuma","year":"2010","journal-title":"Pathol Int"},{"key":"10.1016\/j.dld.2024.05.002_bib0025","first-page":"89","article-title":"When is liver biopsy needed in the diagnosis of primary biliary cirrhosis?","volume":"1","author":"Zein","year":"2003","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.dld.2024.05.002_bib0026","first-page":"1037","article-title":"A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver disease","volume":"42","author":"Pennisi","year":"2022","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.dld.2024.05.002_bib0027","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/gut.49.2.276","article-title":"Jaundice in non-cirrhotic primary biliary cirrhosis: the premature ductopenic variant","volume":"49","author":"Vleggaar","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.dld.2024.05.002_bib0028","series-title":"Sherlock\u00b4s diseases of the liver and biliary system","first-page":"1","author":"Dooley","year":"2011"},{"key":"10.1016\/j.dld.2024.05.002_bib0029","article-title":"Role of ductular reaction and ductular-canalicular junctions in identifying severe primary biliary cholangitis","volume":"4","author":"Overi","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.dld.2024.05.002_bib0030","first-page":"1","article-title":"Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score","volume":"1253","author":"Carbone","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.05.002_bib0031","article-title":"Ductular reaction is a prognostic factor in primary biliary cholangitis","volume":"5","author":"Tan","year":"2023","journal-title":"JHEP Rep Innov Hepatol"},{"key":"10.1016\/j.dld.2024.05.002_bib0032","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ajpath.2017.11.010","article-title":"Hepatic stem\/progenitor cell activation differs between primary sclerosing and primary biliary cholangitis","volume":"188","author":"Carpino","year":"2018","journal-title":"Am J Pathol"},{"key":"10.1016\/j.dld.2024.05.002_bib0033","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/MEG.0000000000001791","article-title":"Relationship between osteoporosis, sarcopenia, vertebral fracture, and osteosarcopenia in patients with primary biliary cholangitis","volume":"33","author":"Saeki","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.05.002_bib0034","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/jgh.13746","article-title":"Risk of secondary osteoporosis due to lobular cholestasis in non-cirrhotic primary biliary cholangitis","volume":"32","author":"Seki","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.05.002_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194418","article-title":"Increased risk of osteoporosis in patients with primary biliary cirrhosis","volume":"13","author":"Liao","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2024.05.002_bib0036","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.3748\/wjg.v24.i31.3513","article-title":"Osteoporosis in primary biliary cholangitis","volume":"24","author":"Danford","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.002_bib0037","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s10067-017-3844-x","article-title":"Association between primary biliary cholangitis and osteoporosis: meta-analysis","volume":"36","author":"Fan","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.dld.2024.05.002_bib0038","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/jbmr.3410","article-title":"Disease duration and stage influence bone microstructure in patients with primary biliary cholangitis","volume":"33","author":"Schmidt","year":"2018","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"10.1016\/j.dld.2024.05.002_bib0039","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/joim.13624","article-title":"Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis: a population-based cohort study","volume":"294","author":"Sch\u00f6nau","year":"2023","journal-title":"J Intern Med"},{"key":"10.1016\/j.dld.2024.05.002_bib0040","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1053\/j.gastro.2010.02.016","article-title":"Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosis","volume":"138","author":"Gua\u00f1abens","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.002_bib0041","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1002\/hep.26466","article-title":"Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis","volume":"58","author":"Gua\u00f1abens","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2024.05.002_bib0042","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/MJT.0b013e3181d7e1d3","article-title":"Parenteral bisphosphonates for osteoporosis in patients with primary biliary cirrhosis","volume":"18","author":"Treeprasertsuk","year":"2011","journal-title":"Am J Ther"},{"key":"10.1016\/j.dld.2024.05.002_bib0043","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/hep.30904","article-title":"Efficacy and safety of 3-year denosumab therapy for osteoporosis in patients with autoimmune liver diseases","volume":"71","author":"Arase","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2024.05.002_bib0044","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40744-017-0074-2","article-title":"Chronic autoimmune epithelitis in Sj\u00f6gren's syndrome and primary biliary cholangitis: a comprehensive review","volume":"4","author":"Selmi","year":"2017","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.dld.2024.05.002_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100746","article-title":"Prevalence and impact of Sj\u00f6gren's syndrome in primary biliary cholangitis: a systematic review and meta-analysis","volume":"27","author":"Deng","year":"2022","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.dld.2024.05.002_bib0046","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.hbpd.2022.05.009","article-title":"Concomitant extrahepatic autoimmune diseases do not compromise the long-term outcomes of primary biliary cholangitis","volume":"21","author":"Chen","year":"2022","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.dld.2024.05.002_bib0047","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jgh.15214","article-title":"Extrahepatic autoimmune diseases in primary biliary cholangitis: prevalence and significance for clinical presentation and disease outcome","volume":"36","author":"Efe","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.05.002_bib0048","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ajg.2016.479","article-title":"Thyroid dysfunction in primary biliary cholangitis: a comparative study at two European Centers","volume":"112","author":"Floreani","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.002_bib0049","first-page":"1094","article-title":"Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease","volume":"29","author":"Silveira","year":"2009","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.dld.2024.05.002_bib0050","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/jcag\/gwz039","article-title":"Prevalence of celiac disease in patients with primary biliary cholangitis","volume":"4","author":"Callichurn","year":"2021","journal-title":"J Can Assoc Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.002_bib0051","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/jcla.20130","article-title":"Low specificity of anti-tissue transglutaminase antibodies in patients with primary biliary cirrhosis","volume":"20","author":"Bizzaro","year":"2006","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.dld.2024.05.002_bib0052","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/gut.2005.075002","article-title":"Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis","volume":"55","author":"Rigamonti","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.dld.2024.05.002_bib0053","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3899\/jrheum.160243","article-title":"Prevalence of systemic sclerosis in primary biliary cholangitis using the new ACR\/EULAR classification criteria","volume":"44","author":"Zheng","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.dld.2024.05.002_bib0054","doi-asserted-by":"crossref","first-page":"119","DOI":"10.14218\/JCTH.2017.00064","article-title":"Risk of cardiovascular events in patients with primary biliary cholangitis - systematic review","volume":"6","author":"Suraweera","year":"2018","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.dld.2024.05.002_bib0055","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.aohep.2019.07.006","article-title":"Patterns of serum lipids derangements and cardiovascular risk assessment in patients with primary biliary cholangitis","volume":"18","author":"Loaeza-Del Castillo","year":"2019","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.dld.2024.05.002_bib0056","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10123046","article-title":"Features of lipid metabolism disorders in primary biliary cholangitis","volume":"10","author":"Reshetnyak","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.dld.2024.05.002_bib0057","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/apt.15533","article-title":"Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response","volume":"50","author":"Murillo Perez","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2024.05.002_bib0058","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/apt.15583","article-title":"Letter: histology is relevant for risk stratification in primary biliary cholangitis","volume":"51","author":"Carbone","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2024.05.002_bib0059","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31810","article-title":"Accuracy of transient elastography in assessing fibrosis at diagnosis in na\u00efve patients with primary biliary cholangitis: a dual cut-off approach","author":"Cristoferi","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2024.05.002_bib0060","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - Renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2024.05.002_bib0061","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.humpath.2012.09.017","article-title":"Evaluation of a new histologic staging and grading system for primary biliary cirrhosis in comparison with classical systems","volume":"44","author":"Kakuda","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.dld.2024.05.002_bib0062","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/his.12384","article-title":"Evaluation of histological staging systems for primary biliary cirrhosis: correlation with clinical and biochemical factors and significance of pathological parameters in prognostication","volume":"65","author":"Chan","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.dld.2024.05.002_bib0063","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","article-title":"Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy","volume":"149","author":"Lammers","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.002_bib0064","first-page":"1497","article-title":"Optimizing therapy in primary biliary cholangitis: alkaline phosphatase at six months identifies one-year non-responders and predicts survival","volume":"43","author":"Murillo Perez","year":"2023","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.dld.2024.05.002_bib0065","first-page":"139","article-title":"Portal pressure is of significant prognostic value in primary biliary cholangitis","volume":"43","author":"Warnes","year":"2023","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.dld.2024.05.002_bib0066","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00535-021-01839-3","article-title":"Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis","volume":"57","author":"Burghart","year":"2022","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.002_bib0067","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1097\/MCG.0b013e3181f18c4e","article-title":"Varices in early histological stage primary biliary cirrhosis","volume":"45","author":"Ali","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.002_bib0068","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0016-5085(92)90771-P","article-title":"Nodular regenerative hyperplasia of the liver in early histological stages of primary biliary cirrhosis","volume":"102","author":"Colina","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.002_bib0069","first-page":"803","article-title":"Prevalence and predictors of esophageal varices in patients with primary biliary cirrhosis","volume":"5","author":"Levy","year":"2007","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.dld.2024.05.002_bib0070","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/MCG.0000000000001433","article-title":"Liver stiffness measured by either magnetic resonance or transient elastography is associated with liver fibrosis and is an independent predictor of outcomes among patients with primary biliary cholangitis","volume":"55","author":"Osman","year":"2021","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.002_bib0071","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII \u2013 renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2024.05.002_bib0072","first-page":"167","article-title":"European Association for the Study of the Liver. EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"145","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2024.05.002_bib0073","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41395-018-0265-7","article-title":"Non-invasive prediction of high-risk varices in patients with primary biliary cholangitis and primary sclerosing cholangitis","volume":"114","author":"Moctezuma-Velazquez","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.002_bib0074","doi-asserted-by":"crossref","first-page":"361","DOI":"10.14309\/ajg.0000000000000056","article-title":"Baveno-VI-guided prediction of esogastric varices in primary biliary cholangitis","volume":"114","author":"Pariente","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.002_bib0075","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2024.05.002_bib0076","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/hep.23095","article-title":"Incidence, risk factors, and survival of hepatocellular carcinoma in primary biliary cirrhosis: comparative analysis from two centers","volume":"50","author":"Cavazza","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2024.05.002_bib0077","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s10620-020-06498-7","article-title":"Incidence of hepatocellular carcinoma in primary biliary cholangitis: a systematic review and meta-analysis","volume":"66","author":"Natarajan","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2024.05.002_bib0078","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.cld.2022.06.011","article-title":"Hepatocellular carcinoma in primary biliary cholangitis","volume":"26","author":"Sy","year":"2022","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.dld.2024.05.002_bib0079","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/gutjnl-2014-308351","article-title":"Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study","volume":"65","author":"Trivedi","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.dld.2024.05.002_bib0080","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/hep.26176","article-title":"Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis: national data from Japan","volume":"57","author":"Harada","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2024.05.002_bib0081","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12016-015-8483-x","article-title":"Incidence and risk factors for hepatocellular carcinoma in primary biliary cirrhosis","volume":"48","author":"Rong","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.dld.2024.05.002_bib0082","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3748\/wjg.15.231","article-title":"Features of hepatocellular carcinoma in cases with autoimmune hepatitis and primary biliary cirrhosis","volume":"15","author":"Watanabe","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.002_bib0083","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.3748\/wjg.v21.i12.3554","article-title":"Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factors","volume":"21","author":"Zhang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.002_bib0084","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.14309\/ajg.0000000000001280","article-title":"Ursodeoxycholic acid response is associated with reduced mortality in primary biliary cholangitis with compensated cirrhosis","volume":"116","author":"John","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.002_bib0085","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2017-315259","article-title":"The British Society of Gastroenterology\/UK-PBC primary biliary cholangitis treatment and management guidelines","author":"Hirschfield","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.dld.2024.05.002_bib0086","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American Association for the Study of Liver Diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2024.05.002_bib0087","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2024.05.002_bib0088","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2024.05.002_bib0089","unstructured":"EASL Policy Statement: risk-based surveillance for hepatocellular carcinoma among patients with cirrhosis 2023, https:\/\/easl.eu\/publication\/easl-policy-statement-risk-based\/."},{"key":"10.1016\/j.dld.2024.05.002_bib0090","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.14309\/ajg.0000000000000557","article-title":"Goals of treatment for improved survival in primary biliary cholangitis: treatment target should be bilirubin within the normal range and normalization of alkaline phosphatase","volume":"115","author":"Murillo Perez","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.002_bib0091","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2024.05.002_bib0092","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2024.05.002_bib0093","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","article-title":"Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis","volume":"113","author":"Poupon","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.002_bib0094","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jhep.2019.04.001","article-title":"Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis","volume":"71","author":"Harms","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2024.05.002_bib0095","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2024.05.002_bib0096","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1053\/j.gastro.2022.08.054","article-title":"Greater transplant-free survival in patients receiving obeticholic acid for primary biliary cholangitis in a clinical trial setting compared to real-world external controls","volume":"163","author":"Murillo Perez","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.002_bib0097","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/hep4.1518","article-title":"Real-world effectiveness of obeticholic acid in patients with primary biliary cholangitis","volume":"4","author":"Roberts","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.dld.2024.05.002_bib0098","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/apt.16181","article-title":"Effectiveness and safety of obeticholic acid in a Southern European multicentre cohort of patients with primary biliary cholangitis and suboptimal response to ursodeoxycholic acid","volume":"53","author":"Gomez","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2024.05.002_bib0099","series-title":"Nota informativa importante su ocaliva (acido obeticolico)","year":"2022"},{"key":"10.1016\/j.dld.2024.05.002_bib0100","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1111\/liv.15386","article-title":"Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid","volume":"42","author":"De Vincentis","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2024.05.002_bib0101","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.27744","article-title":"Fibrates and cholestasis","volume":"62","author":"Ghonem","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2024.05.002_bib0102","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/apt.16336","article-title":"Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitis","volume":"53","author":"Soret","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2024.05.002_bib0103","article-title":"Efficacy and safety of elafibranor in primary biliary cholangitis","author":"Kowdley","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2024.05.002_bib0104","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2312100","article-title":"A phase 3 trial of seladelpar in primary biliary cholangitis","author":"Hirschfield","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2024.05.002_bib0105","first-page":"1507","article-title":"Setanaxib, a first-in-class selective NADPH oxidase 1\/4 inhibitor for primary biliary cholangitis: a randomized, placebo-controlled, phase 2 trial","volume":"43","author":"Invernizzi","year":"2023","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.dld.2024.05.002_bib0106","doi-asserted-by":"crossref","DOI":"10.1038\/ajg.2017.287","article-title":"Effects of bezafibrate on outcome and pruritus in primary biliary cholangitis with suboptimal ursodeoxycholic acid response","volume":"113","author":"Reig","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.002_bib0107","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1714519","article-title":"A placebo-controlled trial of bezafibrate in primary biliary cholangitis","volume":"378","author":"Corpechot","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2024.05.002_bib0108","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/j.gastro.2020.10.001","article-title":"Fibrates for Itch (FITCH) in fibrosing cholangiopathies: a double-blind, randomized, placebo-controlled trial","volume":"160","author":"de Vries","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.002_bib0109","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/0016-5085(88)90442-8","article-title":"Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial","volume":"94","author":"Ghent","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.002_bib0110","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/BF01300759","article-title":"Treatment of pruritus of primary biliary cirrhosis with rifampin","volume":"36","author":"Podesta","year":"1991","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2024.05.002_bib0111","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0140-6736(89)91608-5","article-title":"Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis","volume":"1","author":"Bachs","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2024.05.002_bib0112","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/0016-5085(92)90335-V","article-title":"Effects of long-term rifampicin administration in primary biliary cirrhosis","volume":"102","author":"Bachs","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.002_bib0113","first-page":"943","article-title":"Rifampin is safe for treatment of pruritus due to chronic cholestasis: a meta-analysis of prospective randomized-controlled trials","volume":"26","author":"Khurana","year":"2006","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.dld.2024.05.002_bib0114","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/MCG.0000000000001797","article-title":"Pharmacological therapy of pruritus in primary biliary cholangitis: a systematic review and meta-analysis of randomized clinical trials","volume":"57","author":"Medina-Morales","year":"2023","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.002_bib0115","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1572-0241.2007.01200.x","article-title":"The efficacy and safety of bile Acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus","volume":"102","author":"Tandon","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2024.05.002_bib0116","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/apt.14579","article-title":"Low risk of hepatotoxicity from rifampicin when used for cholestatic pruritus: a cross-disease cohort study","volume":"47","author":"Webb","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2024.05.002_bib0117","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/bmj.289.6436.22","article-title":"Treatment of pruritus due to chronic obstructive liver disease","volume":"289","author":"Duncan","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.dld.2024.05.002_bib0118","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2362.2000.00606.x","article-title":"Effect of cholestyramine on bile acid pattern and synthesis during administration of ursodeoxycholic acid in man","volume":"30","author":"Rust","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.dld.2024.05.002_bib0119","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/17474124.2021.1945919","article-title":"A consensus integrated care pathway for patients with primary biliary cholangitis: a guideline-based approach to clinical care of patients","volume":"15","author":"Hirschfield","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.05.002_bib0120","doi-asserted-by":"crossref","DOI":"10.1002\/hep.20276","article-title":"Quality of life in patients with primary biliary cirrhosis","author":"Poupon","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2024.05.002_bib0121","first-page":"1230","article-title":"Primary biliary cholangitis: perception and expectation of illness","volume":"54","author":"Floreani","year":"2022","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"10.1016\/j.dld.2024.05.002_bib0122","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2021.100081","article-title":"Quality of life in patients with primary biliary cholangitis: a cross-geographical comparison","volume":"4","author":"Montali","year":"2021","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.dld.2024.05.002_bib0123","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1007\/s10620-020-06502-0","article-title":"Understanding fatigue in primary biliary cholangitis","volume":"66","author":"Phaw","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2024.05.002_bib0124","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2015.10.006","article-title":"European Association for the Study of the Liver. EASL clinical practice guidelines: liver transplantation","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2024.05.002_bib0125","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/apt.15060","article-title":"Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades","volume":"49","author":"Harms","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2024.05.002_bib0126","first-page":"278","article-title":"Twenty-year comparative analysis of patients with autoimmune liver diseases on transplant waitlists","volume":"16","author":"Webb","year":"2018","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.dld.2024.05.002_bib0127","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s10620-019-05786-1","article-title":"Outcomes of liver transplant candidates with primary biliary cholangitis: the data from the scientific registry of transplant recipients","volume":"65","author":"Sayiner","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2024.05.002_bib0128","first-page":"1313","article-title":"Transplantation trends in primary biliary cirrhosis","volume":"5","author":"Lee","year":"2007","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.dld.2024.05.002_bib0129","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/j.ajt.2023.02.006","article-title":"OPTN\/SRTR 2021 annual data report: liver","volume":"23","author":"Kwong","year":"2023","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"10.1016\/j.dld.2024.05.002_bib0130","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2018.10.001","article-title":"Factors associated with recurrence of primary biliary cholangitis after liver transplantation and effects on graft and patient survival","volume":"156","author":"Montano-Loza","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.05.002_bib0131","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-6143.2004.00703.x","article-title":"The survival benefit of liver transplantation","volume":"5","author":"Merion","year":"2005","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"10.1016\/j.dld.2024.05.002_bib0132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis in primary biliary cirrhosis: model for decision making","volume":"10","author":"Dickson","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2024.05.002_bib0133","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/gut.20.2.137","article-title":"Serum bilirubin: a prognostic factor in primary biliary cirrhosis","volume":"20","author":"Shapiro","year":"1979","journal-title":"Gut"},{"key":"10.1016\/j.dld.2024.05.002_bib0134","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1600-6143.2009.03006.x","article-title":"Cyclosporine A protects against primary biliary cirrhosis recurrence after liver transplantation","volume":"10","author":"Montano-Loza","year":"2010","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"issue":"Suppl 2","key":"10.1016\/j.dld.2024.05.002_bib0135","first-page":"S25","article-title":"Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation","volume":"15","author":"Duclos-Vallee","year":"2009","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.dld.2024.05.002_bib0136","first-page":"87","article-title":"Liver transplantation for primary biliary cirrhosis: a long-term pathologic study","volume":"9","author":"Khettry","year":"2003","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.dld.2024.05.002_bib0137","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/jhep.2001.20894","article-title":"Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center","volume":"33","author":"Liermann Garcia","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2024.05.002_bib0138","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/01.TP.0000090867.83666.F7","article-title":"The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation","volume":"76","author":"Sanchez","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2024.05.002_bib0139","first-page":"1086","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation: histologic estimate of incidence and natural history","volume":"9","author":"Sylvestre","year":"2003","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.dld.2024.05.002_bib0140","first-page":"1236","article-title":"Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.dld.2024.05.002_bib0141","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2020.03.043","article-title":"Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis","author":"Corpechot","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2024.05.002_bib0142","first-page":"866","article-title":"Ursodeoxycholic acid decreases incidence of primary biliary cholangitis and biliary complications after liver transplantation: a meta-analysis","volume":"27","author":"Pedersen","year":"2021","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.dld.2024.05.002_bib0143","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jhep.2015.07.038","article-title":"Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence","volume":"63","author":"Bosch","year":"2015","journal-title":"J Hepatol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865824007394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865824007394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T01:06:49Z","timestamp":1725412009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865824007394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":143,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1590865824007394"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2024.05.002","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Position paper of the Italian Association for the Study of the Liver (AISF): Management and treatment of primary biliary cholangitis","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2024.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}